Dilip Shanghvi

Dilip Shanghvi

Dilip Shanghvi (#91)

Our story is all about incremental growth. We're not looking for big leaps; we prefer small jumps.

  • $ 26 B
  • Pharmaceuticals
  • India
  • M
  • 70 Years

About Me

The son of a pharmaceuticals distributor, Dilip Shanghvi borrowed $200 from his father to start Sun Pharmaceutical Industries in 1983 to make psychiatric drugs. The company is India's most valuable listed pharma outfit and gets two-thirds of its $5.3 billion annual revenue from overseas markets. He grew Sun through a series of acquisitions, the biggest of which was the 2014 purchase of scandal-tainted rival Ranbaxy Laboratories for $4 billion. In 2023, Sun Pharma completed the $576 million acquisition of U.S.-based Concert Pharmaceuticals.
About Images

Achievements

Career Highlights

A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Dilip Shanghvi’s rise and global influence.

  • #79   Billionaires (2025)

Wealth Growth

Net Worth Growth Over Time

Tracking Dilip Shanghvi’s net worth journey over the years, highlighting key growth phases and financial milestones.

Current Net Worth: $25.8B (February 5, 2026)